Aristeia Capital’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$559K Buy
+5,531
New +$573K 0.01% 400
2025
Q4
Sell
-2,600
Closed -$330K 646
2025
Q3
$330K Sell
2,600
-54
-2% -$6.43K 0.01% 311
2025
Q2
$325K Sell
2,654
-85
-3% -$9.71K 0.01% 284
2025
Q1
$277K Buy
+2,739
New +$267K 0.01% 276
2024
Q3
Sell
-4,240
Closed -$364K 400
2024
Q2
$364K Buy
+4,240
New +$356K 0.01% 185

Other funds holding EHC

Aristeia Capital's EHC Position: Q2 2026 in Review

Aristeia Capital opened a new position in Encompass Health (EHC) in Q2 2026: 5,531 shares worth $559K. The stake represents 0.01% of the portfolio and ranks #400 among its holdings. This is a return to the name: Aristeia Capital previously reported a position in EHC as recently as Q3 2025.

Aristeia Capital first reported a position in EHC in Q2 2024 and has held it in 5 quarters since. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Aristeia Capital held 5,531 shares of Encompass Health worth $559K as of Q2 2026.
  • Encompass Health was a new Aristeia Capital position in Q2 2026.
  • Encompass Health made up 0.01% of Aristeia Capital's portfolio in Q2 2026, its #400 holding.
  • Aristeia Capital first reported a position in Encompass Health in Q2 2024 and has held it in 5 quarters since.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Aristeia Capital's 13F filing for Q2 2026, filed 14 Aug 2026.